1. Market Research
  2. > Healthcare
  3. > General Medicine and Specialty Medicine Market Trends
  4. > Europe Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)

The Europe Nuclear imaging market is growing at a healthy trend. Nuclear imaging is the use of radioisotopes for the diagnosis of diseases. The two major types of Nuclear imaging used commonly are PET and SPECT. Till recently, SPECT imaging was the mainstream modality for nuclear medicine applications like nuclear cardiology procedures. However, the trend is soon going to change because of global shortage of molybdenum-99 isotope which is in turn will lead to shortage of Technetium-99, which is the daughter product of molybdenum. Hence, PET imaging products which include hybrid PET-CT scanners hold a potential market size in coming years. The cost associated with PET-CT service can be as high as $275,000 per year. PET market is expected to witness more growth compared to SPECT imaging as it provides higher resolution images and the lack of availability of technetium-99m is propelling industry to look for alternative diagnostic procedures. Analyzing the application segment of SPECT and PET, PET is majorly being used in oncology because of good quality of imaging while SPECT is majorly used in cardiology segment accounting for almost 90% of the market share in cardiology. The European countries have a rising aging population and disease incidence and require advanced technologies like nuclear imaging for diagnosis of diseases. There are good healthcare facilities available making these technologies more accessible. The high per capita income makes these facilities affordable. These are the drivers of the European Nuclear imaging market.

Market is segmented into two major segments SPECT (Technetium-99m (TC-99m), Thallium-201 (TL-201), Iodine (I-123) and others) and PET (Fluorine-18, Rubidium-82 (RB-82) and others). The Market is segmented based on application market into SPECT (cardiology, lymphoma, thyroid, neurology and others) and PET (oncology, cardiology, neurology and others),by geography market (UK, France, Germany, Italy and others). Major players in the market are Cardiarc Ltd., Digirad Corporation, Gamme Medica Inc., GE healthcare, Hologic Inc. etc.



Drivers: Major factors for the growth of the market are increasing use of SPECT and PET analysis in radiopharmaceuticals, increased awareness of people for radiopharmaceuticals, and ready availability of radiopharmaceuticals. Novel applications such as Alzheimers and continually expanding oncology application segment also drive the market.



Constraints: The short half- life of radioisotopes, high capital investment, regulatory guidelines and reimbursement issues are the constraints in this market.



What the report offers?

1) Market Definition for the specified topic along with identification of key drivers and restraints for the market.

2) Market analysis for the European Nuclear Market in Healthcare Industry, with region specific assessments and competition analysis on a global and regional scale.

3) Identification of factors instrumental in changing the market scenarios, rising prospective opportunities and identification of key companies which can influence the market on a global and regional scale.

4) Extensively researched competitive landscape section with profiles of major companies along with their strategic initiatives and market shares.



5)Identification and analysis of the Macro and Micro factors that affect the European Nuclear imaging Market in Healthcare Industry on both global and regional scale.

6) A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

Table Of Contents

Europe Nuclear Imaging Market - Growth, Trends And Forecasts (2014 - 2019)
1. Introduction
1.1 Study Deliverables
1.2 Market Definition
1.3 Sizing Units
1.4 Base Currency
1.5 Review and Forecast Period Years
1.6 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Analysis Methodology
2.3 Econometric Forecast Model
2.4 Research Assumptions
3. Executive Summary
4. Key Inferences
5. Market Overview and Industry Trends
5.1 Current Market Scenario
5.2 Technology Overview
5.3 New Developments
5.4 Industry Value-Chain Analysis
5.5 Product Life-Cycle Analysis
5.6 Product Benchmarking
5.7 Investment Analysis
5.8 Porter's Five Forces
5.8.1 Bargaining Power of Suppliers
5.8.2 Bargaining Power of Consumers
5.8.3 Threat of New Entrants
5.8.4 Threat of Substitute Products and Services
5.8.5 Competitive Rivalry within the Industry
6. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
6.1 Market Drivers
6.2 Market Restraints
6.3 Key Challenges
6.4 Current Opportunities in the Market
7. Market Segmentation
7.1 Diagnostic Technologies
7.1.1 SPECT Radioisotopes
7.1.1.1 Technetium-99m (TC-99m)
7.1.1.2 Thallium-201 (TL-201)
7.1.1.3 Iodine (I-123)
7.1.1.4 Others
7.1.2 PET Radioisotopes
7.1.2.1 Fluorine-18
7.1.2.2 Rubidium-82 (RB-82)
7.1.2.3 Others
7.2 By Applications
7.2.1 SPECT
7.2.1.1 Cardiology
7.2.1.2 Lymphoma
7.2.1.3 Thyroid
7.2.1.4 Neurology
7.2.1.5 Others
7.2.2 PET
7.2.2.1 Oncology
7.2.2.2 Cardiology
7.2.2.3 Neurology
7.2.2.4 Others
7.3 By Geography
7.3.1 Europe
7.3.1.1 Germany
7.3.1.2 UK
7.3.1.3 France
7.3.1.4 Italy
7.3.1.5 Spain and Portugal
7.3.1.6 Scandinavia
7.3.1.7 BENELUX
7.3.1.8 Rest of Europe
8. Competitive Landscape
8.1 Mergers and Acquisitions
8.2 New Product Launches
8.3 Agreements, Collaborations and Partnerships
9. Key Vendor Analysis
9.1 AGFA-GEVAERT N.V.
9.2 CARDIARC LTD
9.3 DIGIRAD CORPORATION
9.4 GAMMA MEDICA INC
9.5 GE HEALTHCARE
9.6 HOLOGIC INC.
9.7 MEDX INC
9.8 NAVISCAN INC
9.9 POSITRON CORPORATION
9.10 SEGAMI CORPORATION
9.11 SIEMENS HEALTHCARE
10. Analyst Outlook for Investment Opportunities
11. Future Outlook of the Market

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the Way

  • $ 6995
  • Industry report
  • September 2016
  • by GBI Research

Frontier Pharma: Ophthalmology Therapeutics - Advancements in Disease Understanding Pave Way for Increasingly Diverse Therapeutic Options, with Age-Related Macular Degeneration and Glaucoma Leading the ...

Cardiovascular Surgical Devices: Technologies and Global Markets

Cardiovascular Surgical Devices: Technologies and Global Markets

  • $ 6650
  • Industry report
  • September 2016
  • by BCC Research

Use this report to: - Learn about the trends and developments affecting each type of cardiovascular surgical technology - Analyze trends and opportunities in major regions: North America, Europe, Asia ...

TCR/CAR-T Therapies in Oncology: Analytical Tool

TCR/CAR-T Therapies in Oncology: Analytical Tool

  • $ 8096
  • Industry report
  • August 2016
  • by Bioseeker

Analytical Tools are cancer area specific intelligence and surveillance toolkits within a select number of hot, emerging cancer therapy areas. They are designed to empower biotech/pharma professionals ...


ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.